An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia.
- Resource Type
- Article
- Authors
- Carcao, M. D.; Avila, L.; Leissinger, C.; Blanchette, V. S.; Aledort, L.
- Source
- Haemophilia. Sep2017, Vol. 23 Issue 5, pe444-e447. 4p. 1 Chart, 1 Graph.
- Subject
- *BLOOD coagulation factors
*HEMOPHILIA treatment
*HEMOPHILIA in children
*IMMUNOLOGICAL tolerance
*HEMOPHILIACS
*THERAPEUTICS
- Language
- ISSN
- 1351-8216
The article discusses the results of a survey of the extent and patterns of prophylaxis use in adults and children with severe haemophilia in countries with access to long-term prophylaxis conducted by the International Prophylaxis Study Group (IPSG). Topics covered include definition of severe haemophilia A or B, number of patients on immune tolerance induction (ITI) and the number on BA-prophylaxis.